BIOMAT Database Logo BIOMAT Database Logo

[Research results and prospects in the field of experimental leukemia chemotherapy]. 1979

G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects in the field of physiotherapy].
January 1980, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects in the field of cardiology].
January 1977, Vestnik Akademii meditsinskikh nauk SSSR,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research prospects in the field of theoretical and experimental oncology].
January 1986, Eksperimental'naia onkologiia,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects in the field of rural hygiene].
December 1982, Gigiena i sanitariia,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research development results and prospects in the field of pharmacology].
January 1977, Vestnik Akademii meditsinskikh nauk SSSR,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects in the field of antifungal antibiotics].
May 1978, Antibiotiki,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects in the field of medical genetics].
January 1977, Vestnik Akademii meditsinskikh nauk SSSR,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research development results and prospects in the field of normal physiology].
January 1977, Vestnik Akademii meditsinskikh nauk SSSR,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Results of research and prospects for studies in the field of hematology].
December 1986, Gematologiia i transfuziologiia,
G I Kozinets, and E I Khomchenovskiĭ, and V P Reshchikov, and O K Khanykova, and L V Egorov
[Research results and prospects for development in the field of semisynthetic antibiotics].
February 1984, Antibiotiki,
Copied contents to your clipboard!